1. Antimicrobial Susceptibility Survey of Invasive Neisseria meningitidis, United States 2012-2016.
- Author
-
Potts CC, Rodriguez-Rivera LD, Retchless AC, Hu F, Marjuki H, Blain AE, McNamara LA, and Wang X
- Subjects
- Ampicillin, Anti-Bacterial Agents pharmacology, Anti-Bacterial Agents therapeutic use, Ceftriaxone pharmacology, Ciprofloxacin pharmacology, Humans, Microbial Sensitivity Tests, Penicillins, United States epidemiology, Meningococcal Infections epidemiology, Neisseria meningitidis genetics
- Abstract
Background: Historically, antimicrobial resistance has been rare in US invasive meningococcal disease cases., Methods: Meningococcal isolates (n = 695) were collected through population-based surveillance, 2012-2016, and national surveillance, 2015-2016. Antimicrobial susceptibility was assessed by broth microdilution. Resistance mechanisms were characterized using whole-genome sequencing., Results: All isolates were susceptible to 6 antibiotics (cefotaxime, ceftriaxone, meropenem, rifampin, minocycline, and azithromycin). Approximately 25% were penicillin or ampicillin intermediate; among these, 79% contained mosaic penA gene mutations. Less than 1% of isolates were penicillin, ampicillin, ciprofloxacin, or levofloxacin resistant., Conclusions: Penicillin- and ampicillin-intermediate isolates were common, but resistance to clinically relevant antibiotics remained rare., (Published by Oxford University Press for the Infectious Diseases Society of America 2022.)
- Published
- 2022
- Full Text
- View/download PDF